Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
British Journal of Cancer|July 1, 1990
The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell lineC Meijer, N H Mulder, G A Hospers, et al.
Anticancer Research|February 19, 2002
Delirium after interleukin-2 and alpha-interferon therapy for renal cell carcinomaJ H van Steijn, P Nieboer, G A Hospers, et al.
Anticancer Research|November 20, 2001
Dacarbazine DTIC and carboplatin as an outpatient treatment for disseminated malignant melanomaP Nieboer, N H Mulder, W T Van Der Graaf, et al.
British Journal of Cancer|July 20, 2000
Limitations of the nested reverse transcriptase polymerase chain reaction on tyrosinase for the detection of malignant melanoma micrometastases in lymph nodesA Calogero, H Timmer-Bosscha, H Schraffordt Koops, et al.
Nuclear Medicine and Biology|April 25, 2000
[(11)C]FMAU and [(18)F]FHPG as PET tracers for herpes simplex virus thymidine kinase enzyme activity and human cytomegalovirus infectionsE F de Vries, A van Waarde, M C Harmsen, et al.
International Journal of Cancer|July 15, 1990
A study of human small-cell lung carcinoma (hSCLC) cell lines with different sensitivities to detect relevant mechanisms of cisplatin (CDDP) resistanceG A Hospers, C Meijer, L de Leij, et al.
Cancer Research|April 5, 2000
Monitoring of herpes simplex virus thymidine kinase enzyme activity using positron emission tomographyG A Hospers, A Calogero, A van Waarde, et al.
Anticancer Research|August 6, 2000
Retargeting of a T cell line by anti MAGE-3/HLA-A2 alpha beta TCR gene transferA Calogero, G A Hospers, K M Krüse, et al.
Annals of Surgical Oncology|August 24, 2011
Use of S-100B to evaluate therapy effects during bevacizumab induction treatment in AJCC stage III melanomaS Kruijff, E Bastiaannet, A H Brouwers, et al.
The Journal of Antimicrobial Chemotherapy|June 26, 1999
Prevention of febrile leucopenia after chemotherapy in high-risk breast cancer patients: no significant difference between granulocyte-colony stimulating growth factor or ciprofloxacin plus amphotericin BC P Schröder, E G de Vries, N H Mulder, et al.
Pageof 3